The Legend Holdings-backed molecular diagnostics tool provider will use the $91.6m to help bring its products to market.

Prosus Ventures contributed to a round that more than doubled the total raised by the peer-to-peer learning platform to about $150m.

Dai-ichi Life, Marui Group, Ricoh Leasing and GMO chipped into the third tranche of a $68.6m round for the microfinance provider.

Salesforce Ventures co-led a round that pushed the data protection software developer's valuation past the $1bn mark.

Panasonic-backed Conductive Ventures reinvested in a round that lifted the credit building app developer's total funding to $77m.

CR Pharma was among the investors in a $45.8m round that pushed the gene therapy developer's funding to about $170m in the past 14 months.

Kissei Pharmaceutical has become the cancer immunotherapy developer's first corporate investor, in a series D round bringing its overall funding to $93.5m.

SoftBank Opportunity Fund has backed a debt and equity round that reportedly valued the hair appointment management platform at $250m.

The series D round helped Sedgwick and NewYork-Presbyterian-backed care optimisation platform developer LeanTaas push its overall funding past the $250m mark.

Konruns Pharma came on board as Nuance closed a round that will fund the clinical progress of its small molecule anti-tumour drug candidate.